All sponsors

Daewoong Pharmaceutical Co. LTD.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-36
RECRUITING0
READOUTS ≤12 MONTHS1
Open Daewoong Pharmaceutical Co. LTD. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
DWP712 inj.
NCT07013279
P3Not yet recruitingGlabellar Lines3242025-12-31
DWP16001 0.3mg
NCT06606093
P3Not yet recruitingType 2 Diabetic Nephropathy3482026-09-01
DWN12088
NCT05389215
P2Active, not recruitingIdiopathic Pulmonary Fibrosis1022026-10-13 (+29 mo)
DWP16001
NCT07619833
P3Not yet recruitingT2DM (Type 2 Diabetes Mellitus)5102027-11
DWP14012 40mg (Fexuprazan)
NCT07730138
P3Not yet recruitingGastric Ulcer3842028-04-15
DWP450 20 U
NCT07783763
P3Not yet recruitingGlabellar Lines1202028-05
DWP14012 20mg
NCT07746518
P3Not yet recruitingHealed Erosive Esophagitis4202029-08